May 27th 2024
Australia, Québec, and Sweden have defined processes for reimbursements by health technology assessments, but the United States has a low reliance rate.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Navigating the Changing Tides of PBM Audits: A Forecast and Strategy for Independent Pharmacies
February 28th 2024By understanding the nuances of PBM audit strategies, pharmacies can implement proactive measures to mitigate risks of recoupment, payment suspensions, and, in severe cases, network termination.
Read More
Meeting the Challenges in Behavioral Health Care With Hybrid Pharmacy Approach
October 26th 2023The hybrid pharmacy model represents a significant step forward in providing the best possible care for individuals struggling with behavioral health conditions, ultimately improving their outcomes and overall well-being.
Read More
Why Data Point to Hospital At-Home Care as Next Evolution of Clinical Medicine
October 26th 2023With health systems undergoing a necessary reevaluation of how they allocate their funding into the future, initial data support the need for them to offer a hospital-at-home option for patients they serve.
Read More
Importance of Patient Navigation in Specialty Pharmacy
October 25th 2023Many patients face significant challenges in accessing their specialty medications, which highlights the importance of pharmacy-deployed patient navigation programs designed to help resolve nonclinical, system-related barriers to care.
Read More
Independent Pharmacy Files Lawsuit Against CVS Health, Caremark, Aetna Based on DIR Fees
September 28th 2023The National Community Pharmacists Association said the action was sent into motion by wrongful penalties for Medicare Part D prescriptions, called pharmacy direct and indirect remuneration fees.
Read More